Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: A lesion associated with tubular carcinoma

American Journal of Clinical Pathology

Volumn 107, Issue 5, 1997, Pages 561-566

  Goldstein, Neal S ^a   O'Malley, Barbara A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Adenosis; Atypical ductal hyperplasia; Breast; Intraductal carcinoma

Indexed keywords

APOCRINE CARCINOMA; ARTICLE; BREAST BIOPSY; BREAST DUCT ECTASIA; BREAST HYPERPLASIA; CARCINOMA IN SITU; CONTROLLED STUDY; DISEASE ASSOCIATION; FIBROCYSTIC BREAST DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

EID: 0030891697     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/107.5.561     Document Type: Article

References (43)

1. Weidner N. Malignant breast lesions that may mimic benign tumors. Semin Diag Pathol. 1995;12:2-13.
2. Cooper HS, Patchefsky AS, Krall RA. Tubular carcinoma of the breast. Cancer. 1978;42:2334-2342.
3. Patchefsky AS, Sheber GS, Schwartz GF, et al. The pathology of breast cancer detected by mass population screening. Cancer. 1977;40:1659-1670.
4. Taylor HB, Nords HJ. Well-differentiated carcinoma of the breast. Cancer. 1970;25:687-692.
5. Tobon H, Salazar H. Tubular carcinoma of the breast. Arch Pathol Lab Med. 1977;101:310-316.
6. Peters GN, Wolff M, Haagensen CD. Tubular carcinoma of the breast: clinical pathologic correlations based on 100 cases. Ann Surg. 1981;93:138-149.
7. Carstens PHB. Tubular carcinoma of the breast. Am J Clin Pathol. 1978;70:204-210.
8. Carstens PHB, Huvos A, Foote FW, et al. Tubular carcinoma of the breast: a clinicopathologic study of 35 cases. Am J Clin Pathol. 1972;58:231-238.
9. Lagios MD, Rose MR, Margolin FR. Tubular carcinoma of the breast: association with multicentricity, bilaterality, and family history of mammary carcinoma. Am J Clin Pathol. 1980;73:25-30.
10. Oberman HA, Fidler WJ. Tubular carcinoma of the breast. Am J Surg Pathol. 1979;13:387-395.
11. Deos PH, Norris HJ. Well-differentiated (tubular) carcinoma of the breast: a clinicopathologic study of 145 pure and mixed cases. Am J Clin Pathol. 1982;78:1-7.
12. Eusebi V, Betts CM, Bussolati G. Tubular carcinoma: a variant of secretory breast carcinoma. Histopathology. 1979;3:407-419.
13. Parl FF, Richardson LD. The histologic and biologic spectrum of tubular carcinoma of the breast. Hum Pathol. 1983;14:694-698.
14. Feig SA, Shaber GS, Patchefsky AS, et al. Tubular carcinoma of the breast: mammographic appearance and pathological correlation. Radiology. 1978;129:311-314.
15. McDivitt RW, Boyce W, Gersell D. Tubular carcinoma of the breast: clinical and pathological observations concerning 135 cases. Am J Surg Pathol. 1982;6:401-411.
16. Page DL, Anderson TJ. Diagnostic Histopathology of the Breast. Edinburgh, Scotland: Churchill Livingstone; 1987.
17. Elston CW, Ellis IO. Pathologic prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-410.
18. Page DL, DuPont WD, Rogers LW, et al. Atypical hyperplastic lesions of the female breast: a long-term follow-up study. Cancer. 1985;55:2698-2708.
19. Fechner RE. Ductal carcinoma involving the lobule of the breast: a source of confusion with lobular carcinoma in situ. Cancer. 1971;28:274-281.
20. Azzopardi JG. Problems in Breast Pathology. London, England: Saunders; 1979:203.
21. Kerner H, Lichtig C. Lobular cancerization: incidence and differential diagnosis with lobular carcinoma in situ of breast. Histopathology. 1986;10:621-629.
22. Rasbridge SA, Millis RR. Carcinoma in situ involving sclerosing adenosis: a mimic of invasive carcinoma. Histopathology. 1995;27:269-273.
23. Abati AD, Kimmel M, Rosen PP. Apocrine mammary carcinoma: a clinicopathologic study of 72 cases. Am J Clin Pathol. 1990;94:371-377.
24. Chan JKC, Ng WF. Sclerosing adenosis cancerized by intraductal carcinoma. Pathology. 1987;19:425-428.
25. Rosenblum MC, Purazzella R, Rosen PP. Is microglandular adenosis a precancerous disease? A study of carcinoma arising therein. Am J Surg Pathol. 1986;10:237-245.
26. Eusebi V, Collina G, Bussolati G. Carcinoma in situ in sclerosing adenosis of the breast: an immunocytochemical study. Semin Diag Pathol. 1989;6:146-152.
27. Nielsen BB. Adenosis tumor of the breast: a clinicopathological investigation of 27 cases. Histopathology. 1987;11:1259-1275.
28. Oberman HA, Markey BA. Noninvasive carcinoma of the breast presenting in adenosis. Mod Pathol. 1991;4:31-35.
29. Carter DJ, Rosen PP. Atypical apocrine metaplasia in sclerosing lesions of the breast: a study of 51 patients. Mod Pathol. 1991;4:1-5.
30. Lee K, Chan JKC, Gwi E. Tubular adenosis of the breast: a distinctive benign lesion mimicking invasive carcinoma. Am J Surg Pathol. 1996;20:46-54.
31. Seidman JD, Ashton M, Lefkowitz M. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up. Cancer. 1996;77:2529-2537.
32. Wells CA, McGregor IL, Makunura P, et al. Apocrine adenosis: a precursor of aggressive breast cancer? J Clin Pathol. 1995;48:737-742.
33. Yates AJ, Ahmed A. Apocrine carcinoma and apocrine metaplasia. Histopathology. 1988;13:228-231.
34. Lennington WJ, Jensen RA, Dalton LW, et al. Heterogeneity of individual lesions. Cancer. 1994;73:118-124.
35. Holland R, Peterse J, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diag Pathol. 1994;11:167-180.
36. Eberlein TJ, Connolly JL, Schnitt SJ, et al. Predictors of local recurrence following conservative breast surgery and radiation therapy. Arch Surg. 1990;125:771-777.
37. Schnitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer. 1994;74:1746-1751.
38. Spivack B, Khanna MM, Tafra L, et al. Margin status and local recurrence after breast-conserving surgery. Arch Surg. 1994;129:952-957.
39. Foote FW, Stewart FW. Comparative studies of cancerous versus noncancerous breasts. Ann Surg. 1945;121:197-222.
40. Haagensen CD. Blunt Ducts. Anonymous Diseases of the Breast. 3rd ed. Philadelphia, Pa: Saunders; 1986:78-80.
41. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 1975;55:231-271.
42. Bussolati G, Cattani MG, Gugliotta P, et al. Morphologic and functional aspects of apocrine metaplasia in dysplastic and neoplastic breast tissue. Ann NY Acad Sci. 1986;464:262-274.
43. Izuo M, Okagaki T, Richart RM, et al. DNA content in "apocrine metaplasia" of fibrocystic disease of the breast. Cancer. 1971;27:643-650.